The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
Authors:
- Paolo BiancheriPBPaolo Biancheri
- Sylvia Lf PenderSPSylvia Lf Pender
- Francesca AmmoscatoFAFrancesca Ammoscato
- Paolo GiuffridaPGPaolo Giuffrida
- Gianluca SampietroGSGianluca Sampietro
- Sandro ArdizzoneSASandro Ardizzone
- Amir GhanbariAGAmir Ghanbari
- Renata CurciarelloRCRenata Curciarello
- Alessandra PasiniAPAlessandra Pasini
- Giovanni MonteleoneGMGiovanni Monteleone
- Gino R CorazzaGCGino R Corazza
- Thomas T MacDonaldTMThomas T MacDonald
Open Access
- 8 July 2013
- journal article
- Published by Springer Nature in Fibrogenesis & Tissue Repair
- Vol. 6 (1) , 13
Abstract
Background: Interleukin (IL)-17A and IL-17E (also known as IL-25) have been implicated in fibrosis in various tissues. However, the role of these cytokines in the development of intestinal strictures in Crohn’s disease (CD) has not been explored. We investigated the levels of IL-17A and IL-17E and their receptors in CD strictured and non-strictured gut, and the effects of IL-17A and IL-17E on CD myofibroblasts.Results: IL-17A was significantly overexpressed in strictured compared with non-strictured CD tissues, whereas no significant difference was found in the expression of IL-17E or IL-17A and IL-17E receptors (IL-17RC and IL-17RB, respectively) in strictured and non-strictured CD areas. Strictured CD explants released significantly higher amounts of IL-17A than non-strictured explants, whereas no difference was found as for IL-17E, IL-6, or tumor necrosis factor-α production. IL-17A, but not IL-17E, significantly inhibited myofibroblast migration, and also significantly upregulated matrix metalloproteinase (MMP)-3, MMP-12, tissue inhibitor of metalloproteinase-1 and collagen production by myofibroblasts from strictured CD tissues.Conclusions: Our results suggest that IL-17A, but not IL-17E, is pro-fibrotic in CD. Further studies are needed to clarify whether the therapeutic blockade of IL-17A through the anti-IL-17A monoclonal antibody secukinumab is able to counteract the fibrogenic process in CD.Keywords
This publication has 39 references indexed in Scilit:
- Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s DiseasePLOS ONE, 2013
- IL-25 drives remodelling in allergic airways disease induced by house dust miteThorax, 2012
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1Cellular Signalling, 2012
- Recent advances in the IL-17 cytokine familyCurrent Opinion in Immunology, 2011
- Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-β1–Dependent and –Independent MechanismsThe Journal of Immunology, 2011
- Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependentJournal of Experimental Medicine, 2010
- Cytokines mediating the induction of chronic colitis and colitis-associated fibrosisMucosal Immunology, 2008
- Phenotypic and functional features of human Th17 cellsJournal of Experimental Medicine, 2007